流動性止血材の世界市場レポート 2025年

流動性止血材市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.6％で、13億7,000万米ドルに成長します。予測期間の成長は、外科手術数の増加、慢性疾患の有病率の上昇、低侵襲手術の需要拡大、外科治療を必要とする老年人口の拡大に起因しています。予測期間における主な動向としては、高度な生体工学材料の統合、スマート止血材の開発、ロボット支援および低侵襲手術手技、患者別・個別化止血ソリューションの採用、止血材の高度なカスタマイズなどが挙げられます。

流動性止血材市場の成長を牽引するのは、外科手術件数の増加です。この増加の背景には、高齢化によって加齢に伴う手術の需要が高まっていることや、技術の進歩によって手術がより安全で身近なものになったことがあります。流動性止血材は、手の届きにくい場所や従来の方法では効果がないような場所での出血をコントロールする外科手術において、特に有用です。例えば、2024年6月、米国を拠点とする専門非政府組織である国際美容整形外科学会（ISAPS）の報告書によると、2023年の外科手術と非外科手術の総数は前年比3.4％増加し、3,490万件に達したことが明らかになりました。このように、手術件数の増加が流動性止血材市場の拡大に寄与しています。

流動性止血材市場の主要企業は、進化する外科手術のニーズに対応するため、No-swell技術などの先進止血剤の開発に注力しています。No-Swell技術とは、液体を吸収して膨張しない止血材のことで、腫れが合併症を引き起こす可能性のある手術に適しています。例えば、2023年1月、米国の外科技術企業であるMedcura Inc.は、LifeGel流動性技術でFDAの画期的医療機器指定を受けた。ライフジェルは、腫れが許容されない手術中の出血をコントロールするために設計されています。これは、特に止血の腫脹に関連する問題に対処した、最初で唯一の流動性止血ゲルです。この吸収性薬剤は膨潤することなく水分が保たれ、すぐに使用できるため、神経損傷や麻痺などのリスクを軽減できる可能性があります。費用対効果に優れ、抗菌性を保持し、比較的透明で組織に接着するため、複雑な外科手術における出血管理に、より安全で効果的なソリューションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界流動性止血材PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の流動性止血材市場：成長率分析
• 世界の流動性止血材市場の実績：規模と成長, 2019-2024
• 世界の流動性止血材市場の予測：規模と成長, 2024-2029, 2034F
• 世界流動性止血材総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の流動性止血材市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アクティブ止血剤
• 受動止血剤
• 複合止血鉗子
• 世界の流動性止血材市場：素材別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 豚ゼラチン
• 牛ゼラチン
• 世界の流動性止血材市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一般外科
• 心臓手術
• 血管外科
• 神経脊椎外科
• 整形外科
• その他の用途
• 世界の流動性止血材市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 外来手術センター
• 世界の流動性止血材市場、活性止血剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フィブリンシーラント
• トロンビンベースの止血剤
• コラーゲンベースの止血剤
• 生分解性ポリマー止血材
• 世界の流動性止血材市場受動止血鉗子の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガーゼベースの止血鉗子
• スポンジとパッド
• セルロース系止血材
• 顆粒系止血剤
• 世界の流動性止血材市場複合止血材のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• フィブリノーゲンとトロンビンの配合製品
• コラーゲンとフィブリン配合製品
• 合成複合止血剤
• 生体吸収性複合止血材

第7章 地域別・国別分析

• 世界の流動性止血材市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の流動性止血材市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 流動性止血材市場：競合情勢
• 流動性止血材市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Baxter International Inc.
• B Braun Melsungen AG
• Becton Dickinson and Company
• Cook Medical Inc.
• Teleflex Incorporated
• Mallinckrodt Pharmaceuticals
• Integra LifeSciences Holdings Corporation
• Gelita Medical GmbH
• Ferrosan Medical Devices A/S
• Marine Polymer Technologies Inc
• Axio Biosolutions Private Limited
• Hemostasis LLC
• Aegis Lifesciences Private Limited
• Medcura Health Inc
• Arch Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 流動性止血材市場2029：新たな機会を提供する国
• 流動性止血材市場2029：新たな機会を提供するセグメント
• 流動性止血材市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Flowable hemostats are gelatinous medical devices designed to control bleeding during surgery by adapting to irregular wound shapes for effective application. They aid clotting by creating a physical barrier and activating the body's coagulation cascade, making them suitable for use in complex or delicate surgical areas.

The main types of flowable hemostats are active hemostats, passive hemostats, and combination hemostats. Active hemostats are specialized medical agents that actively contribute to the blood clotting process, enhancing hemostasis during surgeries or in bleeding situations. They can be made from materials such as porcine gelatin and bovine gelatin and are used in various surgical fields, including general, cardiac, vascular, neuro and spine, and orthopedic surgeries. These hemostats are designed to meet the needs of different end users, including hospitals, clinics, and ambulatory surgery centers.

The flowable hemostats market research report is one of a series of new reports from The Business Research Company that provides flowable hemostats market statistics, including flowable hemostats industry global market size, regional shares, competitors with a flowable hemostats market share, detailed flowable hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the flowable hemostats industry. This flowable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The flowable hemostats market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growth in elective surgeries, rising adoption of personalized medicine, increased healthcare spending, and expansion of healthcare infrastructure in emerging markets.

The flowable hemostats market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the increasing number of surgical procedures, rising prevalence of chronic diseases, growing demand for minimally invasive surgeries, and an expanding geriatric population requiring surgical care. Major trends in the forecast period include integration of advanced bioengineered materials, development of smart hemostatic products, robotic-assisted and minimally invasive surgical techniques, adoption of patient-specific and personalized hemostatic solutions, and advanced customization of hemostats.

The growth of the flowable hemostats market is expected to be driven by the rising number of surgical procedures. This increase is attributed to an aging population, which creates a higher demand for age-related surgeries, as well as technological advancements that have made surgeries safer and more accessible. Flowable hemostats are particularly valuable in surgical procedures for controlling bleeding in hard-to-reach areas or where traditional methods might be ineffective. For example, in June 2024, a report by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, revealed that the total number of surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million compared to the previous year. Thus, the growing number of surgical procedures is contributing to the expansion of the flowable hemostats market.

Major companies in the flowable hemostats market are concentrating on developing advanced hemostatic agents, such as no-swell technology, to meet the evolving needs of surgical procedures. No-swell technology describes a hemostatic agent that does not absorb fluids and expand, making it suitable for surgeries where swelling could lead to complications. For example, in January 2023, Medcura Inc., a US-based surgical technology company, received FDA breakthrough device designation for its LifeGel flowable technology. LifeGel is designed to control bleeding during surgeries where swelling is not acceptable. It is the first and only flowable hemostatic gel specifically addressing issues related to hemostatic swelling. The absorbable agent remains hydrated and ready-to-use without swelling, potentially reducing risks such as nerve injury and paralysis. It is cost-effective, retains antimicrobial properties, is relatively transparent, and adheres to tissues, offering a safer and more effective solution for managing bleeding in complex surgical procedures.

In May 2022, Ethicon, a company based in the United States that specializes in surgical technologies, purchased GATT Technologies B.V. for an undisclosed sum. The goal of this acquisition was to strengthen Ethicon's portfolio of hemostatic and sealant solutions by incorporating GATT Technologies' advanced products to enhance surgical results. GATT Technologies B.V., located in the Netherlands, is recognized for its innovative advancements in hemostatic and sealant products used in medical applications.

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

North America was the largest region in the flowable hemostats market in 2024. The regions covered in the flowable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the flowable hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The flowable hemostats market consists of sales of synthetic flowable hemostats, fibrin sealant-based hemostats, and collagen-based flowable hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Flowable Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on flowable hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for flowable hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The flowable hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats
• 2) By Material: Porcine Gelatin; Bovine Gelatin
• 3) By Application: General Surgery; Cardiac Surgery; Vascular Surgery; Neuro And Spine Surgery; Orthopedic Surgery; Other Applications
• 4) By End User: Hospital And Clinics; Ambulatory Surgery Centers
• Subsegments:
• 1) By Active Hemostats: Fibrin Sealants; Thrombin-Based Hemostats; Collagen-Based Hemostats; Biodegradable Polymer Hemostats
• 2) By Passive Hemostats: Gauze-Based Hemostats; Sponges and Pads; Cellulose-Based Hemostats; Granule-Based Hemostats
• 3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products; Collagen and Fibrin Combination Products; Synthetic Combination Hemostats; Bioresorbable Combination Hemostats
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Medtronic plc; Medline Industries Inc.; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Flowable Hemostats Market Characteristics

3. Flowable Hemostats Market Trends And Strategies

4. Flowable Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Flowable Hemostats Growth Analysis And Strategic Analysis Framework

• 5.1. Global Flowable Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Flowable Hemostats Market Growth Rate Analysis
• 5.4. Global Flowable Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Flowable Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Flowable Hemostats Total Addressable Market (TAM)

6. Flowable Hemostats Market Segmentation

• 6.1. Global Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Active Hemostats
• Passive Hemostats
• Combination Hemostats
• 6.2. Global Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Porcine Gelatin
• Bovine Gelatin
• 6.3. Global Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• General Surgery
• Cardiac Surgery
• Vascular Surgery
• Neuro And Spine Surgery
• Orthopedic Surgery
• Other Applications
• 6.4. Global Flowable Hemostats Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Clinics
• Ambulatory Surgery Centers
• 6.5. Global Flowable Hemostats Market, Sub-Segmentation Of Active Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fibrin Sealants
• Thrombin-Based Hemostats
• Collagen-Based Hemostats
• Biodegradable Polymer Hemostats
• 6.6. Global Flowable Hemostats Market, Sub-Segmentation Of Passive Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gauze-Based Hemostats
• Sponges and Pads
• Cellulose-Based Hemostats
• Granule-Based Hemostats
• 6.7. Global Flowable Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fibrinogen and Thrombin Combination Products
• Collagen and Fibrin Combination Products
• Synthetic Combination Hemostats
• Bioresorbable Combination Hemostats

7. Flowable Hemostats Market Regional And Country Analysis

• 7.1. Global Flowable Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Flowable Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Flowable Hemostats Market

• 8.1. Asia-Pacific Flowable Hemostats Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Flowable Hemostats Market

• 9.1. China Flowable Hemostats Market Overview
• 9.2. China Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Flowable Hemostats Market

• 10.1. India Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Flowable Hemostats Market

• 11.1. Japan Flowable Hemostats Market Overview
• 11.2. Japan Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Flowable Hemostats Market

• 12.1. Australia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Flowable Hemostats Market

• 13.1. Indonesia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Flowable Hemostats Market

• 14.1. South Korea Flowable Hemostats Market Overview
• 14.2. South Korea Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Flowable Hemostats Market

• 15.1. Western Europe Flowable Hemostats Market Overview
• 15.2. Western Europe Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Flowable Hemostats Market

• 16.1. UK Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Flowable Hemostats Market

• 17.1. Germany Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Flowable Hemostats Market

• 18.1. France Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Flowable Hemostats Market

• 19.1. Italy Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Flowable Hemostats Market

• 20.1. Spain Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Flowable Hemostats Market

• 21.1. Eastern Europe Flowable Hemostats Market Overview
• 21.2. Eastern Europe Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Flowable Hemostats Market

• 22.1. Russia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Flowable Hemostats Market

• 23.1. North America Flowable Hemostats Market Overview
• 23.2. North America Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Flowable Hemostats Market

• 24.1. USA Flowable Hemostats Market Overview
• 24.2. USA Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Flowable Hemostats Market

• 25.1. Canada Flowable Hemostats Market Overview
• 25.2. Canada Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Flowable Hemostats Market

• 26.1. South America Flowable Hemostats Market Overview
• 26.2. South America Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Flowable Hemostats Market

• 27.1. Brazil Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Flowable Hemostats Market

• 28.1. Middle East Flowable Hemostats Market Overview
• 28.2. Middle East Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Flowable Hemostats Market

• 29.1. Africa Flowable Hemostats Market Overview
• 29.2. Africa Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Flowable Hemostats Market Competitive Landscape And Company Profiles

• 30.1. Flowable Hemostats Market Competitive Landscape
• 30.2. Flowable Hemostats Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Flowable Hemostats Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. B Braun Melsungen AG
• 31.3. Becton Dickinson and Company
• 31.4. Cook Medical Inc.
• 31.5. Teleflex Incorporated
• 31.6. Mallinckrodt Pharmaceuticals
• 31.7. Integra LifeSciences Holdings Corporation
• 31.8. Gelita Medical GmbH
• 31.9. Ferrosan Medical Devices A/S
• 31.10. Marine Polymer Technologies Inc
• 31.11. Axio Biosolutions Private Limited
• 31.12. Hemostasis LLC
• 31.13. Aegis Lifesciences Private Limited
• 31.14. Medcura Health Inc
• 31.15. Arch Therapeutics Inc.

32. Global Flowable Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Flowable Hemostats Market

34. Recent Developments In The Flowable Hemostats Market

35. Flowable Hemostats Market High Potential Countries, Segments and Strategies

• 35.1 Flowable Hemostats Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Flowable Hemostats Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Flowable Hemostats Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33482_Flowable_Hemostats_GMR_2025